These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6324316)

  • 1. [Cutaneous leishmaniasis in patients returning from the tropics].
    Heimgartner E
    Schweiz Rundsch Med Prax; 1984 Feb; 73(6):165-8. PubMed ID: 6324316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of cutaneous leishmaniasis with glucantime. Apropos of 9 cases].
    Ramos García AN; Pérez Avila J; Pérez Ramos E; Díaz Hernández A; Ruiz Pérez A
    Rev Cubana Med Trop; 1984; 36(2):151-9. PubMed ID: 6399595
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
    Belazzoug S; Neal RA
    Trans R Soc Trop Med Hyg; 1986; 80(4):670-1. PubMed ID: 3544363
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrences of tegumentary leishmaniasis.
    Weigle KA; Valderrama L; Santrich C; Saravia NG
    Lancet; 1985 Sep; 2(8454):557-8. PubMed ID: 2863579
    [No Abstract]   [Full Text] [Related]  

  • 5. Diffuse cutaneous leishmaniasis acquired in Peru.
    Franke ED; Lucas CM; Tovar AA; Kruger JH; De Rivera MV; Wignall FS
    Am J Trop Med Hyg; 1990 Sep; 43(3):260-2. PubMed ID: 2221221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
    Rezzano S; Armas JA; Moreno G; Scorza JV
    Acta Cient Venez; 1984; 35(5-6):394-403. PubMed ID: 6537698
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cutaneous leishmaniasis].
    Vion B
    Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of paromomycin-I against Leishmania garnhami in heterozygote albino mice].
    Rezzano de Raffo S; Moreno G; García J; Scorza JV
    Rev Cubana Med Trop; 1985; 37(1):55-65. PubMed ID: 3915382
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus).
    Chapman WL; Hanson WL; Hendricks LD
    J Parasitol; 1983 Dec; 69(6):1176-7. PubMed ID: 6674468
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
    Costa JM; Marsden PD; Llanos-Cuentas EA; Netto EM; Carvalho EM; Barral A; Rosa AC; Cuba CC; Magalhães AV; Barreto AC
    J Trop Med Hyg; 1986 Dec; 89(6):319-23. PubMed ID: 3806749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of leishmaniasis (author's transl)].
    Barabe P
    Med Trop (Mars); 1981; 41(6):599-605. PubMed ID: 7339417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T; Lehn N; Landthaler M; Stolz W
    Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
    Morsy TA; Essa MH; Aboul Anaan AM; Montasser MF
    J Egypt Soc Parasitol; 1988 Jun; 18(1):341-4. PubMed ID: 2836525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of the indirect immunofluorescence test in the therapeutic follow-up of cutaneous leishmaniasis americana].
    de Souza WJ; Coutinho SG; Marzochi MC; de Toledo LM; Gottlieb MV
    Mem Inst Oswaldo Cruz; 1982; 77(3):247-53. PubMed ID: 6763131
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cutaneous leishmaniasis in Saudi Arabia.
    Fattah AA; Morsy TA; Ismail MA
    J Egypt Soc Parasitol; 1983 Jun; 13(1):9-17. PubMed ID: 6313824
    [No Abstract]   [Full Text] [Related]  

  • 16. American cutaneous leishmaniasis: disappearance of amastigotes from lesions during antimonial therapy.
    Mayrink W; Raso P; Melo MN; Michalick MS; Magalhães PA; Williams P; da Costa CA; Dias M
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):265-9. PubMed ID: 6672988
    [No Abstract]   [Full Text] [Related]  

  • 17. Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004.
    Vega JC; Sanchez BF; Montero LM; Montaña R; Del Pilar Mahecha M; Dueñes B; Baron AR; Reithinger R
    Trop Med Int Health; 2007 Dec; 12(12):1540-4. PubMed ID: 18076562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American cutaneous leishmaniasis.
    Freeman K
    J R Army Med Corps; 1983 Oct; 129(3):167-73. PubMed ID: 6319690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of visceral leishmaniasis].
    Nemery A; Duvivier A; Lefèbvre P
    Rev Med Liege; 1984 Mar; 39(6):238-42. PubMed ID: 6718878
    [No Abstract]   [Full Text] [Related]  

  • 20. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.